نتایج جستجو برای: antineoplastic drugs

تعداد نتایج: 235269  

2011
Massimo Moretti Roberta Bonfiglioli Donatella Feretti Sofia Pavanello Francesca Mussi Maria G Grollino Milena Villarini Anna Barbieri Elisabetta Ceretti Mariella Carrieri Annamaria Buschini Massimo Appolloni Luca Dominici Laura Sabatini Umberto Gelatti Giovanni B Bartolucci Paola Poli Laura Stronati Giuseppe Mastrangelo Silvano Monarca

BACKGROUND Some industrial hygiene studies have assessed occupational exposure to antineoplastic drugs; other epidemiological investigations have detected various toxicological effects in exposure groups labeled with the job title. In no research has the same population been studied both environmentally and epidemiologically. The protocol of the epidemiological study presented here uses an inte...

2009
Pamela A Ratner John J Spinelli Maria Lorenzi Yat Chow Kris Beking Kay Teschke Nhu D Le Richard P Gallagher

Title: Cancer incidence in registered nurses potentially exposed to antineoplastic drugs and adverse pregnancy outcome incidence in their offspring

Journal: :Anticancer research 2009
Andriani G Charpidou Ioannis Gkiozos Sotirios Tsimpoukis Despoina Apostolaki Kalliopi D Dilana Eleni M Karapanagiotou Kostas N Syrigos

UNLABELLED Pulmonary toxicity induced by novel antineoplastic agents has not been well characterized because of the simultaneous or sequential use of drugs and a multimodality therapeutic approach. To further investigate this topic, relevant studies were identified through Medline. The generic names of novel antineoplastic agents and the key words pulmonary toxicity, dyspnea and pneumonitis wer...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Min H Kang C Patrick Reynolds

Defects in apoptotic pathways can promote cancer cell survival and also confer resistance to antineoplastic drugs. One pathway being targeted for antineoplastic therapy is the anti-apoptotic B-cell lymphoma-2 (Bcl-2) family of proteins (Bcl-2, Bcl-XL, Bcl-w, Mcl-1, Bfl1/A-1, and Bcl-B) that bind to and inactivate BH3-domain pro-apoptotic proteins. Signals transmitted by cellular damage (includi...

2012
Stephanie N. Shishido Thu A. Nguyen

Cisplatin treatment has an overall 19% response rate in animal models with malignant tumors. Increasing gap junction activity in tumor cells provides the targets to enhance antineoplastic therapies. Previously, a new class of substituted quinolines (PQs) acts as gap junction enhancer, ability to increase the gap junctional intercellular communication, in breast cancer cells. We examined the eff...

Journal: :Clinical journal of oncology nursing 2006
Jackie Gambrell Susan Moore

Oncology nurses and ancillary support personnel who work in oncology settings are at risk for exposure to antineoplastic drugs in their workplaces. A review of the literature reveals issues of environmental contamination and personal exposure. Although the United States has no formal regulations regarding hazardous drugs, including cytotoxic agents, guidelines have been published and are readil...

Journal: :Cell reports physical science 2021

With the aim of overcoming well-known limitations platinum-based antineoplastic drugs, recent efforts have focused on development new anticancer agents containing metals other than platinum. Among these agents, organopalladium compounds received significant attention due to their generally high stability under physiological conditions. A number shown promising in vitro and vivo antiproliferativ...

2016
Huan Keat Chan Yik Ming Lim

Background: Apart from reducing occupational exposure to cytotoxic hazards, the PhaSeal® closed-system transfer device (CSTD) can extend the beyond-use dates (BUDs) of unfinished vials of antineoplastic drugs for up to 168 hours (seven days). In this study, the total material cost incurred by its use in a Malaysian government-funded hospital was calculated. Methods: A list of vial stability fol...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید